ÂÜÀòÂÒÂ×

Joseph M. Fitzgerald is our executive vice president and president, Interventional Cardiology, a position he has held since July 2020. In this role, he is responsible for developing and bringing to market innovative solutions that diagnose and treat coronary artery disease and structural heart disorders. He served as executive vice president and president, Rhythm Management, from February 2014 until July 2020, having previously served as senior vice president and president, Cardiac Rhythm Management from July 2011. Prior to that, he was senior vice president and president, Endovascular from February 2010 until July 2011 and president and general manager of Peripheral Interventions and president of Electrophysiology. Mr. Fitzgerald held a variety of management positions in our Neurovascular and Peripheral Interventions businesses. These included numerous regional and divisional sales management assignments up to and including his roles as vice president, global marketing for the Neurovascular business and vice president of U.S. sales for the Neurovascular business. Prior to joining Boston Scientific in 1990 as a sales representative, Mr. Fitzgerald was with Anheuser Busch, Inc., where he held a variety of sales, marketing and training assignments. Mr. Fitzgerald holds a B.S. in Business from Indiana University and an M.B.A. from Southern Illinois University with a concentration in Marketing and Finance.